An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.

Shi J, Hou S, Huang J, Wang S, Huan W, Huang C, Liu X, Jiang R, Qian W, Lu J, Wang X, Shi W, Huang R, Chen J

Open source

DOI
10.1039/c6nr08786h
Published
2017 Jul 6
Container
Nanoscale
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/c6nr08786h,
  title = {An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.},
  author = {Shi J and Hou S and Huang J and Wang S and Huan W and Huang C and Liu X and Jiang R and Qian W and Lu J and Wang X and Shi W and Huang R and Chen J},
  year = {2017},
  journal = {Nanoscale},
  doi = {10.1039/c6nr08786h},
  url = {https://doi.org/10.1039/c6nr08786h}
}

RIS

TY  - JOUR
TI  - An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.
AU  - Shi J
AU  - Hou S
AU  - Huang J
AU  - Wang S
AU  - Huan W
AU  - Huang C
AU  - Liu X
AU  - Jiang R
AU  - Qian W
AU  - Lu J
AU  - Wang X
AU  - Shi W
AU  - Huang R
AU  - Chen J
PY  - 2017
JO  - Nanoscale
DO  - 10.1039/c6nr08786h
UR  - https://doi.org/10.1039/c6nr08786h
ER  - 

APA

J, S., S, H., J, H., S, W., W, H., C, H., X, L., R, J., W, Q., J, L., X, W., W, S., R, H., & J, C. (2017). An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.. Nanoscale. https://doi.org/10.1039/c6nr08786h

Source records